SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3649Well then, perhaps your big year is coming in 2004?scaram(o)uche12/18/2003
3648<I>funding has come on gang-busters. It's now comfortably the second bnigel bates12/18/2003
3647Novogen's subsidiary Marshall Edwards made IPO today, CNBC just noting that scaram(o)uche12/18/2003
3646Amgen Forecasts Strong 2004 Financial Performance Monday December 15, 4:00 pm ETscaram(o)uche12/15/2003
3645Phase 3 Data Show Palifermin Improves Patient Reported Outcomes in Cancer Patienscaram(o)uche12/9/2003
3644Last chance for some Dolly memorabilia (she herself is stuffed & residing innigel bates12/9/2003
3643Message 19573422 Once again -- can't say it enough -- thank you, Bill and Mscaram(o)uche12/8/2003
3642Phase III Trial of Rituxan Plus Chemotherapy as a Front-Line Therapy in Aggressiscaram(o)uche12/8/2003
3641BioCentury (thanks, R!) reports that 2003 is the second best funding year, all-tscaram(o)uche12/7/2003
3640ImClone Systems Incorporated Issues Statement Regarding Swissmedic Approval for scaram(o)uche12/1/2003
3639Alexion Pharmaceuticals files $150 mln shelf offer Wednesday November 26, 5:29 pscaram(o)uche11/26/2003
3638really paid off this year!....... U.S. lobbying spending by major drug companiescaram(o)uche11/26/2003
3637PRAECIS PHARMACEUTICALS INCORPORATED Receives FDA Approval for Plenaxis Tuesday scaram(o)uche11/25/2003
3636great recent recommendation, rkrw!........ Lilly Buys Applied Molecular for $40scaram(o)uche11/21/2003
3635Lilly ICOS Announces FDA Approval of Cialis -tadalafil- Friday November 21, 12:3scaram(o)uche11/21/2003
3634Blair backs biotech plan for more UK drug trials By Ben Hirschler, European Phanigel bates11/17/2003
3633No, no thoughts. I haven't looked at them closely in years, lots of years. scaram(o)uche11/14/2003
3632Richard, Any thoughts on IMMU now that AMGN is out of the picture for the anti-muddphudd11/14/2003
3631Martek's Oils Added to Nestle U.S. Infant Formula Friday November 14, 9:27 ascaram(o)uche11/14/2003
3630BVF sells all of ARRY position @ $5/share; and 1.455 million shares of ARNA @ $7mopgcw11/12/2003
3629PDL'S Appeal of Patent Opposition Upheld By European Technical Board of Appescaram(o)uche11/12/2003
3628Telik to offer new stock at $20 a share Thursday November 6, 9:09 am ET NEW YOscaram(o)uche11/6/2003
3627Adolor raises $103.5 mln in public offering Thursday November 6, 12:27 am ET Nscaram(o)uche11/6/2003
3626Drug firm Pharmion prices IPO at $14 Wednesday November 5, 7:05 pm ETsim111/6/2003
3625NeuroMed Technologies Raises US$32 Million In Series C Round Led By MPM Capital keokalani'nui11/4/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News